A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Investigate the Safety and Efficacy of AV608 in Subjects With Idiopathic Detrusor Overactivity.
Phase of Trial: Phase II
Latest Information Update: 02 Jun 2011
At a glance
- Drugs AV 608 (Primary)
- Indications Bladder disorders
- Focus Therapeutic Use
- Sponsors Avera Pharmaceuticals
- 01 Oct 2006 New trial record.